文献速递外周动脉疾病

外周动脉疾病大截肢后生存、再截肢与假肢使用的影响因素

Determinants of Survival, Reamputation, and Prosthetic Use after Major Lower-Limb Amputation for Peripheral Artery Disease: A Retrospective Cohort Study.
PubMed 文献 · Ann Vasc Surg · 2026-04-01

膝下截肢虽再截肢率更高(P<0.001),但假肢使用率更高(38% vs. 14%),5年生存率更高(63% vs. 51%)。脑血管病、心功能不全、房颤、活动性恶性肿瘤和透析依赖与死亡风险增加独立相关,抗凝治疗具保护作用。

要点

  • 膝下截肢较膝上截肢长期生存和功能结局更优,但再截肢率更高。
  • 脑血管病、心功能不全、房颤、活动性恶性肿瘤和透析依赖增加死亡风险。
  • 抗凝治疗与降低死亡风险独立相关。

核心结论

  • 膝下截肢与更好的长期生存和功能结局相关,尽管再截肢率更高。
  • 优化心血管和肾脏合并症可能改善大截肢后的生存。

研究设计与样本

  • 共585例患者,平均年龄72岁,膝上截肢占61%。
  • 分析人口学特征、合并症、截肢水平、再截肢、假肢使用和死亡率,采用Cox回归模型识别预测因素。

主要发现

  • 总体死亡率为45%,平均死亡时间325天。
  • 5年时,脑血管病、心功能不全、房颤、活动性恶性肿瘤和透析依赖与死亡风险增加独立相关,抗凝治疗为保护因素。
  • 脑血管病、心功能不全、房颤和痴呆与更高概率接受膝上而非膝下截肢独立相关。
  • 膝下截肢再截肢率更高(P<0.001),但假肢使用率更高(38% vs. 14%)。
  • 膝下截肢后5年生存率高于膝上截肢(63% vs. 51%)。

关键数值与推荐

  • 统计显著性定义为P<0.05。
  • 膝下截肢再截肢率更高(P<0.001)。
  • 假肢使用率:膝下截肢38% vs. 膝上截肢14%。
  • 5年生存率:膝下截肢63% vs. 膝上截肢51%。

临床怎么用

  • 对于外周动脉疾病需大截肢患者,应评估心血管和肾脏合并症以优化生存。
  • 膝下截肢虽再截肢风险较高,但假肢使用和长期生存更优,决策时应综合考虑。
  • 抗凝治疗可能与降低死亡风险相关,需个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Major lower limb amputation remains a necessary treatment for advanced peripheral artery disease and is associated with substantial mortality and functional limitation. This study aimed to identify clinical factors associated with mortality and rehabilitation outcomes following major lower limb amputation. METHODS: A retrospective review was performed of all patients undergoing major lower limb amputation, above-the-knee (AK) or below-the-knee (BK), between June 2017 and December 2023. Demographic characteristics, comorbidities, amputation level, reamputation, prosthesis use, and mortality were analyzed. Cox regression models were used to identify predictors of mortality and amputation level. Associations were assessed using chi-squared and nonparametric tests where appropriate. Statistical significance was defined as P < 0.05. RESULTS: A total of 585 patients were included (mean age, 72 years), with AK amputations accounting for 61%. Overall mortality was 45%, with a mean time to death of 325 days. At 5 years after major amputation, cerebrovascular disease, cardiac insufficiency, atrial fibrillation, active malignancy, and dialysis dependence were independently associated with increased mortality, while anticoagulant therapy was protective. Regarding amputation level, cerebrovascular disease, cardiac insufficiency, atrial fibrillation, and dementia were independently associated with a higher likelihood of undergoing AK rather than BK amputation. BK amputations were associated with higher reamputation rates (P < 0.001), but greater prosthesis use compared with AK amputations (38% vs. 14%). Five-year survival was higher after BK than AK amputation (63% vs. 51%). CONCLUSION: BK amputation is associated with improved long-term survival and functional outcomes despite higher reamputation rates. Optimization of cardiovascular and renal comorbidities may improve survival following major lower limb amputation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Marcelo Cabral J, Mendes D, Bandeira M, et al. Determinants of Survival, Reamputation, and Prosthetic Use after Major Lower-Limb Amputation for Peripheral Artery Disease: A Retrospective Cohort Study. Ann Vasc Surg. 2026. PMID: 41932598. doi:10.1016/j.avsg.2026.03.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。